G

Genincode PLC
LSE:GENI

Watchlist Manager
Genincode PLC
LSE:GENI
Watchlist
Price: 1.075 GBX -4.44%
Market Cap: £8.1m

Wall Street
Price Targets

GENI Price Targets Summary
Genincode PLC

There are no price targets for GENI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Genincode PLC Competitors:
Price Targets
TNDM
Tandem Diabetes Care Inc
20% Upside
COHU
Cohu Inc
5% Upside
YUMC
Yum China Holdings Inc
19% Upside
ALG
Alamo Group Inc
1% Upside
OGI
OrganiGram Holdings Inc
76% Upside

Revenue
Forecast

33% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
33% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 3 years the compound annual growth rate for Genincode PLC's revenue is 33%. The projected CAGR for the next 2 years is 33%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GENI's stock price target?
Not Available

GENI doesn't have any price targets made by Wall Street professionals.

What is Genincode PLC's Revenue forecast?
Projected CAGR
33%

For the last 3 years the compound annual growth rate for Genincode PLC's revenue is 33%. The projected CAGR for the next 2 years is 33%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett